Skip to main content
. 2024 Dec 19;21(12):e1004505. doi: 10.1371/journal.pmed.1004505

Fig 3. Cumulative incidence of CIN2+ and ICC over 10 years by baseline results.

Fig 3

HPV, human papillomavirus; CIN2+, cervical intraepithelial neoplasia grade 2 or worse; ICC, invasive cervical cancer; follow-up time for CIN2+ was defined as the date of baseline test to the date of the last registered test. Death, emigration and total hysterectomy were considered as competing events for outcome ICC; * artificial increase due to censoring. The participation in testing during follow-up was 87.9% (12,936/14,713) for the whole cohort within 10 years. The participation in testing during follow-up was significantly higher in cytology arm compared to HPV arm, 89.9% (6,655/7,400) vs. 85.9% (6,281/7,313) (p < 0.0001) (Table 2).